Madrigal Pharmaceuticals Ownership & Insider Activity

Madrigal Pharmaceuticals (MDGL) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 39.5% of shares outstanding. Institutional investors hold 55.3%. Over the past 90 days, insiders made 2 sales worth $6.6M.

Shares Outstanding

23.104M

Shares Float

19.656M

Insider Shares Owned

9.130M

Insider % Owned

39.5%

Institutional Shares Held

12.778M

Institutional % Held

55.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$6.6M total

Net Activity

Net Selling

Net Value (90d)

-$6.6M

Madrigal Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 9, 2026	John William Sibold	PRESIDENT AND CEO	SELL	11.583K	$538.65	$6.2M
Aug 17, 2026	Shannon Kelley	GENERAL COUNSEL	SELL	664.000	$514.97	$342K
Jul 17, 2026	John William Sibold	PRESIDENT AND CEO	SELL-OPTIONS	47.500K	$547.30	$1.4M
Jun 1, 2026	David Soergel	CHIEF MEDICAL OFFICER	SELL	1.042K	$495.74	$517K
May 22, 2026	Richard Levy	DIRECTOR	SELL	5.682K	$515.44	$2.9M
May 18, 2026	David Soergel	CHIEF MEDICAL OFFICER	SELL	844.000	$515.90	$435K

Date	Member	Party	Chamber	Action	Amount
Apr 10, 2023	Daniel Goldman	D	House	Sale	$1,001 - $15,000